D
Dennis Gillingham
Researcher at University of Basel
Publications - 67
Citations - 2379
Dennis Gillingham is an academic researcher from University of Basel. The author has contributed to research in topics: Catalysis & Metathesis. The author has an hindex of 19, co-authored 59 publications receiving 2007 citations. Previous affiliations of Dennis Gillingham include Boston College & ETH Zurich.
Papers
More filters
Journal ArticleDOI
Catalytic X–H insertion reactions based on carbenoids
Dennis Gillingham,Na Fei +1 more
TL;DR: The following review will explore the historical development of X-H insertion and give an up-to-date account of the metal catalysts most often employed, including an assessment of their strengths and weaknesses.
Journal ArticleDOI
Ru complexes bearing bidentate carbenes: from innocent curiosity to uniquely effective catalysts for olefin metathesis
Amir H. Hoveyda,Dennis Gillingham,Joshua J. Van Veldhuizen,Osamu Kataoka,Steven B. Garber,Jason S. Kingsbury,Joseph P. A. Harrity +6 more
TL;DR: A new class of Ru-based catalysts, particularly those that do not bear a phosphine ligand, have been demonstrated to promote unique levels of reactivity in a variety of olefin metathesis reactions.
Journal ArticleDOI
Chiral Ru-Based Complexes for Asymmetric Olefin Metathesis: Enhancement of Catalyst Activity through Steric and Electronic Modifications
TL;DR: The present findings illustrate that modified Ru complexes (3e and 3f) deliver reactivity levels that are more than 2 orders of magnitude higher than 3.0 and indicate that structural modifications of chiral complex 3 does not always correspond to those of the related achiral complexes.
Journal ArticleDOI
Highly site- and enantioselective Cu-catalyzed allylic alkylation reactions with easily accessible vinylaluminum reagents.
TL;DR: An efficient method for catalytic asymmetric allylic alkylation (AAA) of allylic phosphates with vinylaluminum reagents is reported, and the hydroalumination/catalytic AAA sequence can be performed in a single vessel, on gram scale.
Journal ArticleDOI
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Mikolaj Slabicki,Mikolaj Slabicki,Mikolaj Slabicki,Zuzanna Kozicka,Zuzanna Kozicka,Georg Petzold,Yen-Der Li,Yen-Der Li,Manisha Manojkumar,Manisha Manojkumar,Manisha Manojkumar,Richard D. Bunker,Katherine A. Donovan,Quinlan L. Sievers,Quinlan L. Sievers,Jonas Koeppel,Jonas Koeppel,Jonas Koeppel,Dakota Suchyta,Dakota Suchyta,Adam S. Sperling,Adam S. Sperling,Emma C. Fink,Emma C. Fink,Jessica A. Gasser,Jessica A. Gasser,Li R. Wang,Steven M. Corsello,Steven M. Corsello,Rob S. Sellar,Rob S. Sellar,Rob S. Sellar,Max Jan,Max Jan,Dennis Gillingham,Claudia Scholl,Stefan Fröhling,Todd R. Golub,Todd R. Golub,Todd R. Golub,Eric S. Fischer,Nicolas H. Thomä,Benjamin L. Ebert,Benjamin L. Ebert,Benjamin L. Ebert +44 more
TL;DR: It is demonstrated that chemical alteration of surface-exposed moieties can confer gain-of-function glue properties to an inhibitor, and this is proposed as a broader strategy through which target-binding molecules could be converted into molecular glues.